John R Moore - Net Worth and Insider Trading

John R Moore Net Worth

The estimated net worth of John R Moore is at least $89,111 dollars as of 2025-07-22. John R Moore is the General Counsel of Edgewise Therapeutics Inc and owns about 6,531 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $88,332. John R Moore is also the VP, General Counsel of Array BioPharma Inc and owns about 20 shares of Array BioPharma Inc (ARRY) stock worth over $779. Details can be seen in John R Moore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John R Moore has not made any transactions after 2025-05-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of John R Moore

To

John R Moore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John R Moore owns 2 companies in total, including Alpine Immune Sciences Inc (ALPN) , and Edgewise Therapeutics Inc (EWTX) .

Click here to see the complete history of John R Moore’s form 4 insider trades.

Insider Ownership Summary of John R Moore

Ticker Company Transaction Date Type of Owner
ALPN Alpine Immune Sciences Inc 2015-06-16 director
EWTX Edgewise Therapeutics Inc 2025-05-02 General Counsel

John R Moore Latest Holdings Summary

John R Moore currently owns a total of 2 stocks. Among these stocks, John R Moore owns 6,531 shares of Edgewise Therapeutics Inc (EWTX) as of May 2, 2025, with a value of $88,332 and a weighting of 99.13%. John R Moore also owns 20 shares of Array BioPharma Inc (ARRY) as of November 29, 2013, with a value of $779 and a weighting of 0.87%.

Latest Holdings of John R Moore

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EWTX Edgewise Therapeutics Inc 2025-05-02 6,531 13.53 88,332
ARRY Array BioPharma Inc 2013-11-29 20 38.95 779

Holding Weightings of John R Moore


John R Moore Form 4 Trading Tracker

According to the SEC Form 4 filings, John R Moore has made a total of 15 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Edgewise Therapeutics Inc is the sale of 1,930 shares on May 2, 2025, which brought John R Moore around $31,749.

According to the SEC Form 4 filings, John R Moore has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the sale of 11,666 shares on November 29, 2013, which brought John R Moore around $67,546.

Insider Trading History of John R Moore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John R Moore Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John R Moore Ownership Network

Ownership Network List of John R Moore

No Data

Ownership Network Relation of John R Moore

Insider Network Chart


John R Moore Owned Company Details

What does Alpine Immune Sciences Inc do?

Who are the key executives at Alpine Immune Sciences Inc?

John R Moore is the director of Alpine Immune Sciences Inc. Other key executives at Alpine Immune Sciences Inc include Senior VP and CFO James Paul Rickey , director & Executive Chairman and CEO Mitchell Gold , and director & 10 percent owner Xiangmin Cui .

Alpine Immune Sciences Inc (ALPN) Insider Trades Summary

Over the past 18 months, John R Moore made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 118,000 shares made by James Paul Rickey , and a net sale of 19 shares made by James N Topper .

In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 118,019 shares of Alpine Immune Sciences Inc (ALPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 118,019 shares.

Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alpine Immune Sciences Inc Insider Transactions

No Available Data

John R Moore Mailing Address

Above is the net worth, insider trading, and ownership report for John R Moore. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John R Moore's mailing address is: Boulder Co 80301.